OPEN-SOURCE SCRIPT
Custom Buy BID Strategy
This Pine Script strategy is designed to identify and capitalize on upward trends in the market using the Average True Range (ATR) as a core component of the analysis. The script provides the following features:
This strategy is ideal for traders looking to automate their buy entries and manage risk with a straightforward trend-following approach. By utilizing customizable settings, it adapts to various market conditions and timeframes.
- Customizable ATR Calculation: Users can switch between different methods of ATR calculation (traditional or simple moving average).
- Adjustable Parameters: The strategy allows for adjustable ATR periods, ATR multipliers, and custom time windows for executing trades.
- Buy Signal Alerts: The strategy generates buy signals when the market shifts from a downtrend to an uptrend, based on ATR and price action.
- Profit and Stop-Loss Management: Built-in take profit and stop-loss conditions are calculated as a percentage of the entry price, allowing for automatic position management.
- Visual Enhancements: The script highlights the uptrend with green lines and optionally colors bars to help visualize market direction.
- Flexible Timeframe: Users can configure a specific date range to activate the strategy, offering more control over when trades are executed.
This strategy is ideal for traders looking to automate their buy entries and manage risk with a straightforward trend-following approach. By utilizing customizable settings, it adapts to various market conditions and timeframes.
Open-source script
In true TradingView spirit, the author of this script has published it open-source, so traders can understand and verify it. Cheers to the author! You may use it for free, but reuse of this code in publication is governed by House rules. You can favorite it to use it on a chart.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.